Greater Suppression of Glucagon, Lipolysis and Ketogenesis With Insulin Glargine U300 as Compared to Glargine U100 in Type 1 Diabetes Mellitus
Diabetes Technology and Therapeutics - United States
doi 10.1089/dia.2019.0231
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2020
Authors
Publisher
Mary Ann Liebert Inc